SZT2 and epilepsy: The phenotypes were largely heterogeneous and formed a continuum of characteristics from early‐onset epileptic encephalopathy to mild ID without epilepsy, which may be associated with the alteration in residual protein function because truncating mutations cause complete loss of SZT2 function.